Aktiesnakken — December 2009
-
ja..
-
men havde forstået at det primært drejede sig om tests til dyr
-
Men det er da faktisk en udemærket ting.... kan heller ikke forstå hvorfor ordlyden er en anden end den plejer at være
-
BioPorto Diagnostics? has granted ALPCO Diagnostics the rights to promote and sell its immunoassays on the US and Canadian markets
-
de plejer bare at sige at de har tilknyttet en ny distributør... De må have lavet en ekslusiv aftale om dyre NGAL salg i USA og Canda
-
tror ikke man skal undervurdere det marked, er der nogen der har nogle tal? bortset fra den remse der tidligere har været?
-
nu må vi endelig ikke glemme at nævne at GEN er over 80 igen....
-
min remse? Som det er nu tror jeg dyre-NGAL står for den største vækst
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind